Lilly(LLY) - 2023 Q3 - Earnings Call Presentation

Q3 2023 Earnings Call NOVEMBER 2, 2023 Agenda INTRODUCTION AND RECENT KEY EVENTS Dave Ricks, Chair and Chief Executive Officer Q3 2023 FINANCIAL RESULTS Anat Ashkenazi, Chief Financial Officer R&D UPDATE Dan Skovronsky, M.D., Ph.D., Chief Scientific and Medical Officer CLOSING REMARKS Dave Ricks, Chair and Chief Executive Officer QUESTION AND ANSWER SESSION SAFE HARBOR PROVISION This presentation contains forward-looking statements that are based on management's current expectations, but actual results may ...